This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lerman, B. B. Articles by Belardinelli, L. Search for Related Content PubMed PubMed Citation Articles by Lerman, B. B. Articles by Belardinelli, L.

Circulation, Vol 80, 1536-1543, Copyright © 1989 by American Heart Association

ARTICLES

Electrophysiologic effects of dipyridamole on atrioventricular nodal conduction and supraventricular tachycardia. Role of endogenous adenosine

BB Lerman, RC Wesley and L Belardinelli
Department of Medicine, University of Virginia Medical Center, Charlottesville.

Exogenous adenosine has been shown to have potent electrophysiologic effects and antiarrhythmic properties within the atrioventricular (AV) node. Endogenous adenosine, a nucleoside with an increased release signaled by ischemia and hypoxia, is not believed to exert significant effects during homeostatic conditions. Recent experimental evidence suggests, however, that under normoxic conditions, the amount of adenosine released may be sufficient to mediate some of its physiologic effects. This study was designed to test the hypothesis that in humans the electrophysiologic effects of endogenously released adenosine on AV nodal conduction can be demonstrated under normoxic conditions by inhibiting uptake and degradation of the nucleoside. In the first protocol, the effects of intravenous dipyridamole (0.56 mg/kg bolus i.v., 5 micrograms/kg/minute infusion), a nucleoside-transport blocker that elevates endogenous plasma levels of adenosine, on AV nodal conduction were evaluated in seven patients. At a constant atrial paced cycle length, dipyridamole increased the AH interval from 110 +/- 19 to 164 +/- 26 msec, p = 0.002 (+/- SEM). Aminophylline (5.6 mg/kg i.v.), a competitive antagonist of adenosine, completely reversed the effects of dipyridamole on AV nodal conduction. Similarly, dipyridamole increased the cycle length at which pacing-induced AV nodal Wenckebach occurred, from 348 +/- 31 (control) to 388 +/- 33 msec (dipyridamole) (p = 0.002). In a second protocol, the effects of intravenous dipyridamole were evaluated in another group of six patients who had supraventricular tachycardia (SVT) in which the AV node was part of the reentrant circuit.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				D. M. Dennis, M.J. P. Raatikainen, J. R. Martens, and L. Belardinelli Modulation of Atrioventricular Nodal Function by Metabolic and Allosteric Regulators of Endogenous Adenosine in Guinea Pig Heart Circulation, November 15, 1996; 94(10): 2551 - 2559. [Abstract] [Full Text]

				J. B. Conti, L. Belardinelli, D. B. Utterback, and A. B. Curtis Endogenous Adenosine Is an Antiarrhythmic Agent Circulation, March 15, 1995; 91(6): 1761 - 1767. [Abstract] [Full Text]

				L. I. Ganz and P. L. Friedman Supraventricular Tachycardia N. Engl. J. Med., January 19, 1995; 332(3): 162 - 173. [Full Text] [PDF]

				G. L. Dattilo, C. E. Eiriksson Jr, and R. E. Vestal Increased Ventricular Response Rate During Exercise in Patients With Atrial Fibrillation Treated With Theophylline Arch Intern Med, April 1, 1992; 152(4): 797 - 803. [Abstract] [PDF]

				A. C. Rankin and B. A. McGovern Adenosine or Verapamil for the Acute Treatment of Supraventricular Tachycardia? Ann Intern Med, March 15, 1991; 114(6): 513 - 515. [Abstract] [PDF]